Exact Mass: 301.2956184

Exact Mass Matches: 301.2956184

Found 19 metabolites which its exact mass value is equals to given mass value 301.2956184, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sphinganine

D-Erythro-1,3-dihydroxy-2-aminooctadecane

C18H39NO2 (301.2980634)


Sphinganine, also known as c18-dihydrosphingosine or safingol, is a member of the class of compounds known as 1,2-aminoalcohols. 1,2-aminoalcohols are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Thus, sphinganine is considered to be a sphingoid base lipid molecule. Sphinganine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Sphinganine can be found in a number of food items such as agar, biscuit, herbs and spices, and pasta, which makes sphinganine a potential biomarker for the consumption of these food products. Sphinganine can be found primarily in blood, feces, and urine, as well as throughout most human tissues. Sphinganine exists in all eukaryotes, ranging from yeast to humans. In humans, sphinganine is involved in few metabolic pathways, which include globoid cell leukodystrophy, metachromatic leukodystrophy (MLD), and sphingolipid metabolism. Sphinganine is also involved in few metabolic disorders, which include fabry disease, gaucher disease, and krabbe disease. Moreover, sphinganine is found to be associated with pregnancy. Sphinganine is a lyso-sphingolipid protein kinase inhibitor. It has the molecular formula C18H39NO2 and is a colorless solid. Medicinally, safingol has demonstrated promising anticancer potential as a modulator of multi-drug resistance and as an inducer of necrosis. The administration of safingol alone has not been shown to exert a significant effect on tumor cell growth. However, preclinical and clinical studies have shown that combining safingol with conventional chemotherapy agents such as fenretinide, vinblastine, irinotecan and mitomycin C can dramatically potentiate their antitumor effects. Currently in Phase I clinical trials, it is believed to be safe to co-administer with cisplatin . Sphinganine belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Thus, sphinganine is considered to be a sphingoid base lipid molecule. Sphinganine is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Sphinganine exists in all living species, ranging from bacteria to humans. Within humans, sphinganine participates in a number of enzymatic reactions. In particular, sphinganine can be converted into 3-dehydrosphinganine through its interaction with the enzyme 3-ketodihydrosphingosine reductase. In addition, sphinganine can be converted into sphinganine 1-phosphate; which is catalyzed by the enzyme sphingosine kinase 2. Outside of the human body, sphinganine has been detected, but not quantified in, several different foods, such as Mexican oregano, jostaberries, winter squash, angelica, and epazotes. This could make sphinganine a potential biomarker for the consumption of these foods. Sphinganine blocks postlysosomal cholesterol transport by inhibiting low-density lipoprotein-induced esterification of cholesterol and causing unesterified cholesterol to accumulate in perinuclear vesicles. It has been suggested that endogenous sphinganine may inhibit cholesterol transport in Niemann-Pick Type C (NPC) disease (PMID: 1817037). D004791 - Enzyme Inhibitors KEIO_ID D078 D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity. D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity.

   

(2R,3R)-2-Aminooctadecane-1,3-diol

(2R,3R)-2-Aminooctadecane-1,3-diol

C18H39NO2 (301.2980634)


   
   

DErySphinganine

DErySphinganine

C18H39NO2 (301.2980634)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

MLS001066334-01!D-erythro-Dihydrosphingosine764-22-7

MLS001066334-01!D-erythro-Dihydrosphingosine764-22-7

C18H39NO2 (301.2980634)


   

Sphinganine

D-erythro-2-Amino-1,3-octadecanediol

C18H39NO2 (301.2980634)


A 2-aminooctadecane-1,3-diol having (2S,3R)-configuration. D004791 - Enzyme Inhibitors D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity. D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity. DL-erythro-Dihydrosphingosine is a potent inhibitor of PKC and phospholipase A2 (PLA2)[1][2].

   

Dihydrosphingosine

L-erythro Sphinganine (d18:0)

C18H39NO2 (301.2980634)


D004791 - Enzyme Inhibitors D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity. D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity. DL-erythro-Dihydrosphingosine is a potent inhibitor of PKC and phospholipase A2 (PLA2)[1][2].

   

Tetradecyldiethanolamine

2-[2-hydroxyethyl(tetradecyl)amino]ethanol

C18H39NO2 (301.2980634)


CONFIDENCE standard compound; INTERNAL_ID 1002; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9366; ORIGINAL_PRECURSOR_SCAN_NO 9363 CONFIDENCE standard compound; INTERNAL_ID 1002; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9364; ORIGINAL_PRECURSOR_SCAN_NO 9362 CONFIDENCE standard compound; INTERNAL_ID 1002; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9357; ORIGINAL_PRECURSOR_SCAN_NO 9355 CONFIDENCE standard compound; INTERNAL_ID 1002; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9378; ORIGINAL_PRECURSOR_SCAN_NO 9377 CONFIDENCE standard compound; INTERNAL_ID 1002; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9396; ORIGINAL_PRECURSOR_SCAN_NO 9394 CONFIDENCE standard compound; INTERNAL_ID 1002; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9391; ORIGINAL_PRECURSOR_SCAN_NO 9389

   

Sphinganine (d18:0)

Sphinganine (d18:0)

C18H39NO2 (301.2980634)


   

2S-aminooctadecane-1,3R-diol

Safingol ( L-threo-sphinganine)

C18H39NO2 (301.2980634)


   

Enigmol

2S-aminooctadecane-3S,5S-diol

C18H39NO2 (301.2980634)


   

Tetrabutylammonium Acetate

Tetrabutylammonium Acetate

C18H39NO2 (301.2980634)


   

decanoic acid, compound with dibutylamine (1:1)

decanoic acid, compound with dibutylamine (1:1)

C18H39NO2 (301.2980634)


   

Safingol

DL-erythro-Dihydrosphingosine

C18H39NO2 (301.2980634)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors DL-erythro-Dihydrosphingosine is a potent inhibitor of PKC and phospholipase A2 (PLA2)[1][2].

   

tetra-n-butylammonium dihydrogentrifluoride

tetra-n-butylammonium dihydrogentrifluoride

C16H38F3N (301.2956184)


   
   

acetic acid,N,N-dimethyltetradecan-1-amine

acetic acid,N,N-dimethyltetradecan-1-amine

C18H39NO2 (301.2980634)


   

DL-THREO-DIHYDROSPHINGOSINE

DL-1,3-DIHYDROXY-2-AMINO-OCTADECANE

C18H39NO2 (301.2980634)


D004791 - Enzyme Inhibitors DL-erythro-Dihydrosphingosine is a potent inhibitor of PKC and phospholipase A2 (PLA2)[1][2].

   

Sphingosine (d18:0)

SPH(d18:0)

C18H39NO2 (301.2980634)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved